NFKB inhibitor alpha ; Homo sapiens

10 Article(s)
Pub. Year
#Total Relationships
1 30391277 Development of mKO2 fusion proteins for real-time imaging and mechanistic investigation of the degradation kinetics of human IκBα in living cells. 2019 Feb 1
2 19665001 The microtubule-targeting agent T0070907 induces proteasomal degradation of tubulin. 2009 Oct 16 1
3 17869053 NF-kappaB activation as a key mechanism in ethanol-induced disruption of the F-actin cytoskeleton and monolayer barrier integrity in intestinal epithelium. 2007 Sep 1
4 12815011 Evidence that nuclear factor-kappa B activation is critical in oxidant-induced disruption of the microtubule cytoskeleton and barrier integrity and that its inactivation is essential in epidermal growth factor-mediated protection of the monolayers of intestinal epithelia. 2003 Jul 1
5 11864973 Ubiquitin/proteasome-dependent degradation of D-type cyclins is linked to tumor necrosis factor-induced cell cycle arrest. 2002 May 10 1
6 12209633 Proteasome inhibition leads to NF-kappaB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. 2002 Aug 1
7 11312270 Inducible nitric-oxide synthase is regulated by the proteasome degradation pathway. 2001 Jun 29 1
8 11055326 Bcl-2 intersects the NFkappaB signalling pathway and suppresses apoptosis in ventricular myocytes. 2000 Oct 4
9 9573251 The major component of IkappaBalpha proteolysis occurs independently of the proteasome pathway in respiratory syncytial virus-infected pulmonary epithelial cells. 1998 Jun 2
10 9727009 Bcl-2 activates the transcription factor NFkappaB through the degradation of the cytoplasmic inhibitor IkappaBalpha. 1998 Sep 11 2